Richard D. Katz, Vice President and CFO at ARGOS THERAPEUTICS INC (ARGS), sold 104,435 shares at $0.16 ($17K) on 2018-01-09, disclosed to the SEC on 2018-01-12.
Scheduled sale ($17k) by Vice President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ICGN | SELL | 2011-08-22 | $48 | — | Filing → |
| ICGN | SELL | 2011-08-12 | $215 | — | Filing → |